Skip to main content

Table 3 Factors predictive of MACE by Cox regression Model

From: Long-term oral nitrate therapy is associated with adverse outcome in diabetic patients following elective percutaneous coronary intervention

  Univariate   Multivariate  
Variable HR CI P value HR CI P value
Baseline characteristics
Age, years 1.03 1.01-1.10 0.02 1.01 0.96-1.06 0.81
Male 1.31 0.42-4.09 0.64    
BMI 0.92 0.81-1.05 0.23    
Hypertension 0.61 0.14-2.67 0.51    
Smoking 1.04 0.39-2.79 0.93    
Insulin therapy 1.61 0.37-7.12 0.53    
Creatinine 1.01 1.00-1.02 0.06 1.01 0.98-1.02 0.12
HbA1c 1.04 0.72-1.50 0.85    
Total cholesterol 0.84 0.45-1.57 0.59    
Triglyceride 0.93 0.63-1.39 0.73    
HDL 0.34 0.03-4.20 0.40    
LDL 0.90 0.40-1.98 0.79    
Triple vessel disease 3.03 0.83-11.07 0.09 1.37 0.16-11.51 0.77
Prior myocardial infarction 1.45 0.54-4.08 0.45    
Prior PCI 1.67 0.62-4.49 0.31    
Drug eluting stent 0.67 0.25-1.82 0.44    
Impaired LVEF < 50% 1.79 0.41-7.87 0.44    
Medications
ISMN 3.88 1.25-12.0 0.02 3.09 1.19-10.21 0.04
Beta blocker 2.06 0.27-15.67 0.49    
CCB 1.58 0.45-5.59 0.48    
Statin 3.60 0.73-17.92 0.12    
ACEI/ARB 1.28 0.36-4.53 0.70    
Aldosterone blocker, 0.40 0.28-8.21 0.83    
  1. Abbreviation similar to Tables 1 and 2.